News on Hematologic_Diseases from BioPortfolio.com http://www.BioPortfolio.com Consolidated Hematologic_Diseases news from BioPortfolio.com Wed, 10 Feb 2010 07:58:15 GMT en Lymphoma Research Foundation announces publication of Mantle Cell reporthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039433&HITNO=0&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039433&THISHREF=http://c.moreover.com/click/here.pl%3fz2538112571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039433&HITNO=0&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039433&THISHREF=http://c.moreover.com/click/here.pl%3fz2538112571%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040037&HITNO=1&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040037&THISHREF=http://c.moreover.com/click/here.pl%3fz2538541694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040037&HITNO=1&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040037&THISHREF=http://c.moreover.com/click/here.pl%3fz2538541694%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCalifornia Chronicle: Atlas of Hematologic Neoplasmshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039176&HITNO=2&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039176&THISHREF=http://c.moreover.com/click/here.pl%3fz2537969993%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039176&HITNO=2&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039176&THISHREF=http://c.moreover.com/click/here.pl%3fz2537969993%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of the American Medical Association: BiomedReports: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039167&HITNO=3&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039167&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039167&HITNO=3&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039167&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964908%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comQuote.com Japan: BiomedReports: News and FDA Updates for Synta (NASDAQ:SNTA), Teva...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036316&HITNO=4&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036316&THISHREF=http://c.moreover.com/click/here.pl%3fz2536569406%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036316&HITNO=4&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036316&THISHREF=http://c.moreover.com/click/here.pl%3fz2536569406%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035372&HITNO=5&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035372&THISHREF=http://c.moreover.com/click/here.pl%3fz2536217649%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035372&HITNO=5&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035372&THISHREF=http://c.moreover.com/click/here.pl%3fz2536217649%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLos Angeles Chronicle: Synta Pharmaceuticals' STA-9090 inhibits WT1 protein in AMLhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034143&HITNO=6&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034143&THISHREF=http://c.moreover.com/click/here.pl%3fz2535663584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034143&HITNO=6&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034143&THISHREF=http://c.moreover.com/click/here.pl%3fz2535663584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: News and FDA Updates for Synta (NASDAQ:SNTA), Teva (NASDAQ:TEVA), Active Biotech (NASDAQ:ACTI)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033945&HITNO=7&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033945&THISHREF=http://c.moreover.com/click/here.pl%3fz2535503644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033945&HITNO=7&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033945&THISHREF=http://c.moreover.com/click/here.pl%3fz2535503644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Chronicle: Synta Announces STA-9090 Results Demonstrating Potent in vitro and in vivo Activity in AMLhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029609&HITNO=8&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029609&THISHREF=http://c.moreover.com/click/here.pl%3fz2533207599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029609&HITNO=8&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029609&THISHREF=http://c.moreover.com/click/here.pl%3fz2533207599%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Synta Announces STA-9090 Results Demonstrating Potent in vitro and in vivo Activity in AMLhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029116&HITNO=9&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029116&THISHREF=http://c.moreover.com/click/here.pl%3fz2533004619%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029116&HITNO=9&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029116&THISHREF=http://c.moreover.com/click/here.pl%3fz2533004619%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Synta Announces STA-9090 Results Demonstrating Potent in vitro and in vivo Activity in AMLhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028981&HITNO=10&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028981&THISHREF=http://c.moreover.com/click/here.pl%3fz2532938081%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028981&HITNO=10&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028981&THISHREF=http://c.moreover.com/click/here.pl%3fz2532938081%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Synta Announces STA-9090 Results Demonstrating Potent in vitro and in vivo Activity in AMLhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028770&HITNO=11&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028770&THISHREF=http://c.moreover.com/click/here.pl%3fz2532850966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028770&HITNO=11&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028770&THISHREF=http://c.moreover.com/click/here.pl%3fz2532850966%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Synta Pharma (SNTA) Preclinical Shows STA-9090 Inhibits Wilms' Tumor 1 Proteinhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028748&HITNO=12&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028748&THISHREF=http://c.moreover.com/click/here.pl%3fz2532840512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028748&HITNO=12&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028748&THISHREF=http://c.moreover.com/click/here.pl%3fz2532840512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: University of Michigan Health System: Blood test could improve graft-versus-host disease treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010570&HITNO=13&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010570&THISHREF=http://c.moreover.com/click/here.pl%3fz2522516837%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4010570&HITNO=13&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4010570&THISHREF=http://c.moreover.com/click/here.pl%3fz2522516837%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Fungal Infections in Hematologic Patients -- Best Strategies for Prevention and Treatmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3977184&HITNO=14&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3977184&THISHREF=http://c.moreover.com/click/here.pl%3fz2504693999%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3977184&HITNO=14&MSIZE=27&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hematologic_Diseases&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3977184&THISHREF=http://c.moreover.com/click/here.pl%3fz2504693999%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGeneral Medicine eJournal: